---
title: "Prenetics Global Limited (PRE.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PRE.US.md"
symbol: "PRE.US"
name: "Prenetics Global Limited"
industry: "Health Care Services"
---

# Prenetics Global Limited (PRE.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Location | US Market |
| Website | [www.prenetics.com](https://www.prenetics.com) |

## Company Profile

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the E...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-16T04:30:13.000Z

**Overall: C (0.43)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 42 / 86 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 201.54% |  |
| Net Profit YoY | 0.77% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.29 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 369.72M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 77.08M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -28.18% | E |
| Profit Margin | -60.39% | E |
| Gross Margin | 59.54% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 201.54% | A |
| Net Profit YoY | 0.77% | C |
| Total Assets YoY | -16.65% | E |
| Net Assets YoY | -10.49% | D |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -165.58% | D |
| OCF YoY | 201.54% | A |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.36 | C |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 17.97% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Prenetics Global Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-28.18%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-60.39%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "59.54%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "201.54%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "0.77%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-16.65%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-10.49%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-165.58%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "201.54%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.36",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "17.97%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Cigna (US.CI) | B | B | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B |
| 03 | Labcorp (US.LH) | B | B | B | C | B | B |
| 04 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B |
| 05 | BrightSpring Health Services (US.BTSG) | C | A | A | D | A | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -7.94 | 53/79 | - | - | - |
| PB | 2.29 | 31/79 | 1.50 | 0.69 | 0.37 |
| PS (TTM) | 4.80 | 61/79 | 3.46 | 2.60 | 2.28 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-12T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 67% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 21.97 |
| Highest Target | 31.00 |
| Lowest Target | 31.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/PRE.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PRE.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PRE.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.